香港旅游攻略交流组

【新闻】墨尔本在未来两年内将承办5次顶尖国际生命科学会议

澳大利亚维多利亚州贸易投资局2019-05-11 02:24:12

墨尔本将在2019年和2020年举办五次顶尖国际生命科学会议提升维多利亚作为全国领先的医疗技术和药物投资目的地的声誉。


2019年的AusMedtech会议,2019年和2020年的AusBiotech全国会议以及2019年和2020年的生物技术投资会议预计将吸引来自澳大利亚和全球各地的数千名代表促进维多利亚的能力并巩固我们在此行业作为全球领先的地位。


这些行业活动最大限度地为维多利亚州公司带来了机会,为投资和国际资本提供了渠道,并为合作伙伴和交流机会提供了促进行业增长的机会。


会议的召开是在维州政府的支持下实现的,维州政府通过其医疗技术和制药部门战略以及该州的创业发展机构LaunchVic,大力支持该行业在维多利亚州的发展。


生命科学是维多利亚州企业和就业的重要增长市场,全球医疗保健支出预计每年增长4%以上。


快速增长的全球医疗设备和诊断行业价值超过1000亿美元,预计到2020年药品需求将增长到1.5万亿美元。


2016年,维州的医疗技术和制药出口增长了40%,达到17亿美元,其中美国和欧洲是我们的主要市场,中国需求继续增长。


维多利亚有能力利用这个机会,在先进制造业,临床试验,研究与开发,教育和技术创新方面拥有强大的能力,并且与美国相比具有吸引力。


维州政府通过包括BioCurate,医药制造创新中心,国家医药科技执行者总部以及与强生公司合作推出的Quickfire挑战等举措和项目积极支持该行业。


Melbourne has secured five premier international life science conferences in 2019 and 2020 – boosting Victoria’s reputation as the nation’s leading medical technology and pharmaceutical investment destination.


The AusMedtech Conference in 2019, AusBiotech National Conferences in 2019 and 2020, and Biotech Invest Conferences in 2019 and 2020 are expected to attract thousands of delegates from across Australia and around the globe – promoting Victoria’s capabilities and reinforcing our position as a global leader in this sector.


These industry events maximise exposure for Victorian companies, provide access to investment and international capital, and open up partnering and networking opportunities that fuel sector growth.


The haul of conferences was achieved with support from the Andrews Labor Government, which is a strong supporter of the industry through its Medical Technologies and Pharmaceuticals Sector Strategy and the state’s startup development agency, LaunchVic.


Life sciences represents a key growth market for Victorian businesses and employment, with global health care spending projected to grow by over four per cent each year.


The rapidly growing global medical device and diagnostic industry is valued at more than $100 billion, and demand for medicines is forecast to grow to $US1.5 trillion by 2020.


In 2016, Victoria’s medtech and pharmaceutical exports grew by 40 per cent to $1.7 billion, with the USA and Europe our key markets and Chinese demand continuing to grow.


Victoria is well placed to capitalise on this opportunity with strong capabilities in advanced manufacturing, clinical trials, research and development, education, and tech innovation, as well as attractive incentives compared to the US.


The Labor Government actively supports the industry through initiatives and projects including BioCurate, the Medicines Manufacturing Innovation Centre, the headquarters for the National MedTech Actuator and partnering with Johnson & Johnson to deliver the Quickfire Challenge: Driving Device Innovation competition.